For the Culture By The Culture. ISSN: 3064-9331.
For decades, federal policy claimed cannabis had no accepted medical use while opioid prescriptions moved through the health care system by the tens of millions. Cannabis Lies Vol. 10 exposes the contradiction behind Schedule I, blocked research, medical cannabis patients, and the institutions that spent years pretending politics was medicine.
Australia’s medical cannabis system expanded rapidly through telehealth and high-volume prescribing. Now regulators are tightening oversight. The TGA and AHPRA are increasing scrutiny on prescribing practices, signaling a shift from rapid patient access toward stricter clinical control that could reshape how doctors prescribe and how patients obtain treatment.
Idaho lawmakers passed a resolution urging voters to reject a medical cannabis initiative before it reaches the ballot. The move highlights how officials are shaping public opinion ahead of a vote, while maintaining strict prohibition and blocking even limited access for patients.
Mississippi maintains strict limits on medical cannabis after Governor Tate Reeves vetoed expansion bills on March 26, 2026. Patients remain unable to use cannabis in hospitals while eligibility and access rules stay tightly controlled. This feature examines what the veto blocks, how it affects patients, and what it means for the state’s growing cannabis market.
Florida’s ballot system claims to give voters power, yet the 2026 election cycle shows how procedural barriers can quietly shut the door on citizen initiatives. Signature thresholds, geographic distribution rules, and court challenges blocked every measure from reaching voters, revealing how cannabis legalization fights are often decided by bureaucratic design long before election day.
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.
